Tibor Keler Insider Trades & Stock Holdings

EXECUTIVE VP & CSO · Celldex Therapeutics, Inc. · Latest filing Jun 25, 2026

Tibor Keler, EXECUTIVE VP & CSO at Celldex Therapeutics, Inc. has 1 Form 4 trade on file since Jun 25, 2026. Latest filing: acquired 115K shares of $CLDX on Jun 25, 2026.

Trades on file
1
Open-market bought
$0
Open-market sold
$0
Net open-market
$0
Latest filing
Jun 25, 2026

All insider trades by Tibor Keler

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$CLDX Buy (Grant or award) 115K $0 — +12.6%+4.6% EXECUTIVE VP & CSO Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Tibor Keler traded

Frequently asked questions

What was Tibor Keler's latest insider trade?

acquired 115K shares of $CLDX on Jun 25, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text